• Revenues up 251.9% to $3,796,140
• Loss down 12.2% to $13,373,824
• Completed platform build-out, progressed enterprise deployments, and secured strategic partnerships

Enlitic Inc, a leading healthcare AI company, has released its 2025 Annual Report, showcasing a year of important progress. The company reported a 251.9% increase in revenues to $3,796,140, while losses were reduced by 12.2% to $13,373,824. Enlitic completed the build-out of its core platform, progressed large-scale enterprise deployments, and secured strategic partnerships with major industry participants, including an expansion of its relationship with GE Healthcare and new partnerships with Philips, Fuji, and Infinitt. The company's focus on improving the quality, structure, and governance of medical imaging data is positioned to address a critical challenge in the healthcare industry, as providers continue to invest heavily in AI, cloud infrastructure, and advanced analytics, but are constrained by the fragmented and inconsistent state of underlying data. Enlitic's approach of integrating AI-driven normalisation and governance directly into the migration process enables healthcare organisations to realise immediate operational benefits while establishing a scalable data foundation for future innovation. The company is now entering a new phase, shifting from platform development to execution and scale, with a focus on converting strategic relationships into recurring revenue and expanding platform adoption across clinical operations, analytics, and AI enablement.

Looking ahead, Enlitic's priorities are to scale deployments, convert strategic relationships into recurring revenue, and expand platform adoption across clinical operations, analytics and AI enablement. The foundations are now in place to drive disciplined expansion and repeatable execution.